Quarterly report pursuant to Section 13 or 15(d)

Business and Organization (Details)

v3.3.0.814
Business and Organization (Details) - USD ($)
$ / shares in Units, $ in Thousands
Aug. 20, 2015
May. 05, 2015
Bio-Reference    
Business Acquisition [Line Items]    
Cash paid at closing date $ 950,010  
Common stock value $ 2,259  
EirGen    
Business Acquisition [Line Items]    
Cash paid at closing date   $ 100,200
Common stock value   33,600
Consideration transferred   $ 133,800
Common Stock    
Business Acquisition [Line Items]    
Stock price $ 12.38 $ 13.88
Common Stock | Bio-Reference    
Business Acquisition [Line Items]    
Common stock received 76,566,147  
Acquired entity share price $ 34.05  
Common Stock | EirGen    
Business Acquisition [Line Items]    
Common stock received   2,420,487